Understanding and Discussing the Implications of the FDA’s Sentinel Initiative

Project Title Understanding and Discussing the Implications of the FDA’s Sentinel Initiative
Date
Tuesday, October 25, 2011
Host

Mark McClellan MD, PhD, Director, Engelberg Center for Health Care Reform, Brooking Institution, Washington DC

Location
Presenters

Janet Woodcock, MD, U.S. Food and Drug Administration, Silver Spring, MD;, Rachel Sherman, MD, MPH, FACP, U.S. Food and Drug Administration, Silver Spring, MD; Melissa Robb, RN, U.S. Food and Drug Administration, Silver Spring, MD; and Richard Platt, MD, MSc, Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA